A $70 million program will try to develop brain implants able to regulate emotions in the mentally ill.
Researchers used an emerging technique to correct the gene behind a fatal immune system disorder in an infant.
A synthetic drug that controls blood sugar in obese mice demonstrates the potential of a DNA-dependent method for developing new chemical compounds.
New technologies give vaccine developers a boost in early development, but large-scale testing and production are bogged down by high costs and lengthy trials.
Academics and pharmaceutical companies alike are looking to electrical implants as an alternative to drugs for treating disease.
An electromechanical limb developed by Segway maker DEKA now needs a manufacturer to mass-produce it.
Animal studies on the revitalizing power of young blood suggest new drug targets for treating conditions like dementia and heart disease.
Electronics companies think the Affordable Care Act will push us to embrace technology to track our health and lifestyles.
The way some emergency doctors are using Glass highlights the promise, and the limitations, of wearable technology.
A new surgical procedure could help people suffering from debilitating wounds.